INDICATIONS AND USAGE（适应症）

TORISEL is indicated for the treatment of advanced renal cell carcinoma.

DOSAGE（服用剂量）

Advanced Renal Cell Carcinoma

The recommended dose of TORISEL for advanced renal cell carcinoma is 25 mg administered as an intravenous infusion over a 30 – 60 minute period once a week.

Treatment should continue until disease progression or unacceptable toxicity occurs.

ADVERSE REACTIONS（不良反应）

Hypersensitivity/Infusion Reactions

Hepatic Impairment

Hyperglycemia/Glucose Intolerance

Infections

Interstitial Lung Disease

Hyperlipidemia

Bowel Perforation

Renal Failure

Wound Healing Complications

Intracerebral Hemorrhage

For full information, please refer to:

https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/95b7dc92-2180-42f1-8699-3c28f609e674/spl-doc?hl=Torisel

Toriselinformation